A detailed history of Lewis Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lewis Asset Management, LLC holds 10,687 shares of ABBV stock, worth $1.88 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
10,687
Previous 10,333 3.43%
Holding current value
$1.88 Million
Previous $1.77 Billion 19.07%
% of portfolio
1.54%
Previous 1.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $57,999 - $70,562
354 Added 3.43%
10,687 $2.11 Billion
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $26,004 - $30,367
168 Added 1.65%
10,333 $1.77 Billion
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $124,020 - $141,309
-776 Reduced 7.09%
10,165 $1.85 Billion
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $1.51 Million - $1.7 Million
10,941 New
10,941 $1.7 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lewis Asset Management, LLC Portfolio

Follow Lewis Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lewis Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lewis Asset Management, LLC with notifications on news.